跳至主要内容
临床试验/NCT00130572
NCT00130572已完成3 期

Randomized Placebo-Controlled Clinical Pilot Trial Regarding the Efficacy of Elidel Cream on Erosive Oral Lichen Planus

University Hospital Tuebingen2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2004年6月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Reduction of a symptom score consisting of involved mucosal area and appearance of pain before and after treatment

研究概览

简要总结

The purpose of this study is to investigate whether topical applied pimecrolimus will lead to improvement of erosive oral lichen planus. This effect will be monitored by reduction of erosive mucosal area and reduction of patient's pain symptoms.

详细描述

Oral lichen planus is a mucosal inflammatory disease of unknown origin. It can be very painful especially if erosions appear on the oral mucosa.

In this study the efficacy of pimecrolimus compared to placebo in treatment of erosive oral lichen planus will be investigated. To this end the subjective pain and the amount of affected mucosa will be monitored before and after treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinically and histologically confirmed diagnosis of erosive oral lichen planus
  • Spontaneous or meal related oral pain
  • No topical therapy 2 weeks prior to study start
  • No systemic therapy 4 weeks prior to study start
  • Signed informed consent

排除标准

  • Pregnant or breast-feeding women
  • Known allergy to macrolide antibiotics
  • Known current active malignant disease or in patient's history
  • Known immunodeficiency or HIV infection
  • Participation at another clinical trial within the last 6 months

结局指标

主要结局

Reduction of a symptom score consisting of involved mucosal area and appearance of pain before and after treatment

次要结局

  • Patient's and investigator's global assessment after 4 and 8 weeks
  • Pimecrolimus blood level after 4 weeks

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验